| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cue Biopharma, Inc. (CUE) has 10 insiders with recent SEC Form 4 filings, including 5 buys and 8 sells. CUE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.88M | $65.63M | - | |
| Other | 125.0K | $4.38M | - | |
| VP | 70.0K | $2.45M | - | |
| Other | 50.0K | $1.75M | - | |
| Dir | 24.4K | $854.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2021 | Suri Anish69 | President And CSO | Sale+OE | 20,000 | $15.07 | $301,354.00 | -17.5% | -54.2% | -79.2% | |
| Oct 1, 2021 | Millar Kerri-Ann | Chief Financial Officer | Sale+OE | 1,251 | $14.21 | $17,782.84 | -10.7% | -22.0% | -84.7% | |
| Sep 24, 2021 | Passeri Daniel R | Chief Executive Officer | Buy | 3,400 | $14.72 | $50,051.40 | +6.5% | -14.2% | -81.7% | |
| Sep 23, 2021 | Suri Anish69 | President And CSO | Sale+OE | 20,000 | $15.23 | $304,646.00 | -21.1% | -21.4% | -82.2% | |
| Mar 16, 2021 | Pienta Kenneth | Chief Medical Officer | Sale+OE | 13,439 | $15.10 | $202,894.45 | -77.1% | -8.2% | -68.9% | |
| Feb 17, 2021 | Pienta Kenneth | Chief Medical Officer | Sale+OE | 20,274 | $15.13 | $306,767.47 | -83.5% | - | - | |
| Jan 20, 2021 | Pienta Kenneth | Chief Medical Officer | Buy | 2,720 | $15.07 | $40,979.52 | +136.0% | - | - | |
| Nov 24, 2020 | Fletcher Aaron G.L.55 | Director | Buy | 6,548 | $12.64 | $82,775.89 | +4.1% | - | - | |
| Sep 30, 2020 | Gray Cameron | Director | Buy | 10,000 | $15.15 | $151,500.00 | +0.7% | - | - | |
| Aug 5, 2020 | Sandercock Colin | SVP, General Counsel And Sec | Sale+OE | 13,274 | $20.00 | $265,480.00 | -43.7% | - | - |